Skip to main content
Caplight Logo









Proven Connect

Proven Connect

Londonprovenconnect.com

Overview

Proven Connect is the translational research arm of the charity Prostate Cancer Research (PCR), focused on supporting and accelerating the commercialization of prostate cancer innovations through seed funding, strategic guidance, and expert networks.

Year Founded

2021

Portfolio Companies

2

Investments

Proven Connect investments
CompanyDateStageLead
Oxford Vacmedix UK LimitedNov 2024Series BCo-investor
StratosvirJun 2024SeedCo-investor

Key People

Jayne Spink

Director

Sonja Lawrence

Associate Director

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon
Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?